Therapeutics for Covid-19 patients
The invention concerns the use of DNA aptamers that can shield the SARS-CoV-2 binding site on the cell, and halt the cell-to-cell spreading of coronavirus.
Artificial heart muscle
This patent is focusing on an artificial heart muscle, an innovative artificial device able to replicate the natural human heart functionalities.
Composition of an hydro-alcoholic solution of grape pomace extract, and application thereof for reducing the exogenus oxidative stress in dermal cell
The invention relates to an hydro-alcoholic solution extract of selected grape pomace, a cosmetic formulation comprising such hydro-alcoholic solution extract, the method for incorporating the hydro-alcoholic solution extract into a cosmetic formulation and the final use of the as-obtained cosmetic formulation.
Material And System For The Therapeutic Treatment Of Joints
The present invention relates to the therapeutic treatment of joints. In particular, the invention relates to a composite material and a treatment system for the regeneration of cartilage tissue
A system for monitoring and treating metabolic disorders
The present invention refers to the field of medical devices, in particular to a system for monitoring and treating metabolic disorders, especially type 2 diabetes.
Hand Exoskeleton device
The patent is related to an exoskeleton for the guidance and assistance of flex extension movements of fingers and cylindrical objects grasping.
Artificial pancreas
The invention concerns an implantable device for the controlled administration of insulin
Personalized vacuum bell for pectus excavatum treatment
The aim of this invention is to create a Vacuum Bell, customized on patient anatomy, suitable for the pectus excavatum correction.
New Dendrimeric Pyrrolidines
The invention proposes a new approach to rare genetic diseases for which no cures are available, only symptomatic treatments through the preparation of novel multivalent molecules active toward the human enzymes responsible for them
Antagonism of B3 adrenoceptor for the treatment of cancer immune tolerance
The invention relates to the use of beta-blocking compounds, in particular the antagonist of ?3 adrenoceptor (?3-ARs), for the treatment of immune-tolerance associated with pathological states, such as cancer.